In order to further confirm the impact of SDHC on tumor invasion and metastasis through lipid accumulation, we utilized orlistat, a fatty acid synthase inhibitor, to decrease the presence of lipid droplets in SDHC knockdown cells. The gene discussed is FASN; the disease is neoplasm.